ArticleACS chemical biology2026
Bacterial Display of Genetically Encoded Macrocyclic Peptide Libraries Using Cysteine-Reactive Unnatural Amino Acids.
Article in ACS chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Cyclic peptides are powerful scaffolds for modulating protein-protein interactions; however, methods for constructing cyclic peptide libraries for cell-surface display applications remain limited. Here, we present a bacterial surface display platform that enables site-specific incorporation of diverse unnatural amino acids (uAAs) into peptides displayed on the surface of Escherichia coli. These uAAs include several cysteine-reactive residues that undergo spontaneous intramolecular reactions with cysteine to generate macrocyclic peptides directly on the bacterial outer membrane. Using high-resolution mass spectrometry, we show that peptide cyclization proceeds efficiently and selectively with no detectable off-target reactions. Further, we demonstrate that this platform supports simultaneous incorporation of two distinct uAAs, enabling the surface display of chemically diverse, drug-like macrocycles. To demonstrate the utility of this platform, we constructed and screened a naïve macrocyclic peptide library against a model target, yielding de novo ligands with conserved sequence motifs and binding affinities similar to those previously identified by phage display. Together, these results establish a robust approach for generating diverse cyclic peptide libraries, thereby expanding the scope of cell-surface display for research and drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.